[Localization of primary hyperaldosteronism].
After diagnosis of primary aldosteronism on the basis of biochemical evidence, the detection of the tumour is of crucial importance in the management of the disease. We reviewed the efficacy of CT-Scan, Iodo-Cholesterol Scintigraphy, digitalized phlebography, adrenal vein sampling for steroid measurements (AVS), and Nuclear Magnetic Resonance (NMR) in 160 hypertensive patients with primary aldosteronism. Diagnosis of Conn's adenoma (n = 96) or Adrenal Hyperplasia (n = 40) was confirmed by surgery or at least two concordant tumour localization tests. Scintigraphy gave a correct diagnosis in 53% of the 51 exams, CT-Scan in 82% of the 85 exams, and phlebography in 79% of 61 exams. Plasma Aldosterone/Cortisol ratio was 5 times higher on the side of adenoma in 55% of the 47 cases but this ratio was also present in 23% of 22 patients with adrenal hyperplasia. Each procedure exhibited few false positive and false negative cases. NMR performed in 15 patients with Conn's adenoma identified all the cases. But tumours displayed a signal close to the liver signal and identical to the normal adrenal. These results and the risk of invasive procedure (failure of catheterization of the right adrenal vein (n = 6) and adrenal haematoma (n = 2) lead us to propose a schema of exploration of patients with primary aldosteronism. The CT-Scan could be performed at the first step once the biological diagnosis confirmed. Phlebography and AVS will be performed only if tumour was less than 1 cm at the CT-Scan despite important biological abnormalities. This schema requires to be validated by a prospective evaluation.
Pagny
J Y
JY
Service d'Hypertension Artérielle et de Médecine Interne, Hôpital Broussais, Didot, Paris.
Chatellier
G
G
Raynaud
A
A
Plouin
P F
PF
Corvol
P
P
D000236:Adenoma / Q000175:diagnosis; D000307:Adrenal Gland Diseases / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000000981:diagnostic imaging; D006965:Hyperplasia / Q000175:diagnosis; D010690:Phlebography; D011877:Radionuclide Imaging; D014057:Tomography, X-Ray Computed
Localisation d'un hyperaldostéronisme primaire.